TWD 32.3
(1.1%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 8.84 Million TWD | 55.33% |
2022 | 5.69 Million TWD | -2.83% |
2021 | 5.85 Million TWD | 0.0% |
2020 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 8.84 Million TWD | 55.33% |
2023 Q4 | 8.84 Million TWD | -26.39% |
2023 Q2 | 12.01 Million TWD | 111.03% |
2022 Q4 | 5.69 Million TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
BIONET Corp. | 55.53 Million TWD | 84.078% |
DIVA Laboratories, Ltd. | 196.2 Million TWD | 95.493% |
Genetics Generation Advancement Corp. | 34.79 Million TWD | 74.588% |
Welgene Biotech Co.,Ltd. | 53.77 Million TWD | 83.554% |
Puriblood Medical Co., Ltd. | 24.24 Million TWD | 63.53% |